Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

14 Oct 2009 07:00

RNS Number : 7141A
Xaar PLC
14 October 2009
 



FOR IMMEDIATE RELEASE

14 October 2009

Xaar plc

INTERIM MANAGEMENT STATEMENT

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 July 2009 to 30 September 2009.

Trading and margins for the third quarter of the year were in line with the Board's expectations and were broadly stable at the levels seen in the first and second quarters of 2009.

Launches of printing machines based on Xaar's Platform 3 technology continue, with eight of our OEM (original equipment manufacturer) customers exhibiting Platform 3 based machines at the recent Label Expo trade show held in Brussels. Sales of Platform 3 products are predominantly to customers based in Western Europe and North America and, whilst continuing to show modest growth over previous quarters, are still subject to the lengthy transition period between product launch and volume sales - a process which is exacerbated by the global recession. Sales of Xaar's other product ranges are consistent with previous periods.

The consolidation of the Group's manufacturing facilities into a single plant in HuntingdonEngland is progressing to schedule. The design and planning phase of the programme is now complete and the first production processes have been relocated successfully. The overall time frame for the project remains at two years from March 2009; the costs and benefits of the project are in line with the original plan.

The Group's balance sheet remains strong. Net cash at 30 September 2009 was £9.6m (31 December 2008: £11.0m, 30 June 2009: £10.3m) after the payment of £1.5m of dividends (2008 final: £0.9m, 2009 interim: £0.6m) in the year to date.

The Board remains satisfied with the continuing stability in trading seen in the period. The overall trading environment remains unchanged from the time of the Half Yearly Report in August 2009.  There is still a lack of forward visibility of customer orders which, together with the ongoing uncertainty in the global business environment, contribute to a level of caution when looking ahead

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Steve Liebmann or Andy Harris

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUBDGSUBGGCX
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.